Wood Group, Creo Medical and Gfinity

The FTSE100 opened the week in negative territory with geopolitical risk weighing on sentiment with traders monitoring North Korea’s reaction to planned military exercises by US and South Korea,” says AJ Bell Investment Director Russ Mould.

Wood Group’s shares edged up in early trading after it clinched a five-year, multimillion dollar contract from Phillips 66 to provide maintenance and support services at the Sweeny refinery near Houston, Texas. Wood Group has supported the refinery for more than 20 years and around 175 of its employees will be based at the refinery to provide the maintenance services.

Creo Medical’s shares rose after its Speedboat RS2 device and the CROMA platform were cleared by the US Food and Drug Administration ahead of schedule. Speedboat RS2 is the first of a range of medical devices in development, powered by the CROMA platform, and enables the minimally invasive removal of early stage cancerous and pre-cancerous lesions in the bowel through an endoscopic procedure. Creo Medical’s shares were up by more than 2.3% in early trading.

“International esports group Gfinity’s shares were up following a partnership with Formula 1. The group has been appointed as partner for the Formula 1 ESports Series which starts in September and gives gamers across the world the chance to show their prowess as they try to become the best virtual Formula 1 driver. Gfinity’s shares were up by over 3.5%.

These articles are for information purposes only and are not a personal recommendation or advice.